C-KIT Mutation Analysis
| Order Code: | CKITB |
| Epic Lab Code: | LAB2876 |
| Order Form: | A-1a Miscellaneous Request or Epic Req |
Commercial Mail-out Laboratory
6240 RCP
356-3527
6240 RCP
356-3527
Specimen:
Whole Blood
Collection Medium:
![]() |
| Lavender top tube 3 mL (EDTA) |
Minimum:
Note: Sample viability 72 hours refrigerated. Sample MUST reach
Mailouts by Friday noon to meet courier pickup.
Preferred Minimum: 3 mL whole blood collected in a lavender
top (EDTA) tube
Absolute Minimum: 1 mL whole blood collected in a lavender
top (EDTA) tube
Analytic Time:
2 weeks upon receipt at reference laboratory
Reference Range:
Not Detected
Comments:
Activating c-kit mutations have been identified in various human
cancers. The mutations are not detected in normal individuals. C-kit
exon 8 and 17 mutations have been described in patients with CBF-AMLs
and usually confer a poor prognosis with increased relapse rate. C-kit
exon 9, 11, 13, 17 mutations have been reported in 90% GIST patients.
The presence of a mutation usually predicts poor survival. C-kit exon
17 mutation has been reported in patients with systemic
mastocytosis.
Except for D816V mutation, most other mutations are believed to be sensitive to Gleevec therapy.
All exons are sequenced and reported if detected.
Except for D816V mutation, most other mutations are believed to be sensitive to Gleevec therapy.
All exons are sequenced and reported if detected.
Methodology:
Polymerase Chain Reaction/Sequencing (PCR)
CPT Code:
83891, 83898(x5), 83904(x10), 83909(x10), and 83892(x5)
